2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.88-$0.002 (-0.23%)
Price as of Aug 21, 2026 7:38 PM EDT- $101.6MMarket Cap
- 40.94%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.88-$0.002 (-0.23%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.88 | ||
Change | +$0.03 (+3.41%) | ||
Open | $0.88 | ||
High | $0.90 | ||
Low | $0.86 | ||
Previous Close | $0.85 | ||
Volume | 708,398 | ||
30-Day Average Volume | 1,025,050 | ||
1-Week Change | 10.54% | ||
1-Month Change | 27.35% | ||
1-Year Change | 40.94% | ||
3-Year Change | -77.72% | ||
5-Year Change | -94.51% | ||
Fundamentals | |||
Shares Outstanding | 115.4M | ||
Total Assets | $60.8M | ||
Market Cap | $101.6M | ||
Enterprise Value | $96.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.4M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$7.4M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $45.9M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 57 | ||
P/B | 3 | ||
P/E | -22 | ||
PEG | N/A | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue